All Stories

  1. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials
  2. Predictive Metagenomic Analysis Reveals a Role of Cutaneous Dysbiosis in the Development of Hidradenitis Suppurativa
  3. Optical coherence tomography of onychomycosis: proposed terminology and a suggestion of practical usage
  4. Psoriasis as a comorbidity of hidradenitis suppurativa
  5. Hidradenitis Suppurativa Area and Severity Index ( HASI ): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa
  6. Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents
  7. Itch and Mental Health in Dermatological Patients across Europe: A Cross-Sectional Study in 13 Countries
  8. Genetic disposition to primary hyperhidrosis: a review of literature
  9. Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials
  10. Inter‐rater and intrarater agreement and reliability in clinical staging of hidradenitis suppurativa/acne inversa
  11. Pain perception in patients with hidradenitis suppurativa
  12. The boiling brain
  13. Evidence‐based hidradenitis suppurativa guidelines – and now all together please
  14. KITTEN following CAT on the long‐term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives
  15. Hidradenitis Suppurativa is a Diagnosis to be Discussed
  16. Thyroid function in psoriasis
  17. Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument
  18. Long-Wave Medical Infrared Thermography: A Clinical Biomarker of Inflammation in Hidradenitis Suppurativa/Acne Inversa
  19. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic
  20. Vascular morphology in normal skin studied with dynamic optical coherence tomography
  21. New pathways to explore in hidradenitis suppurativa
  22. Thyroid function in hidradenitis suppurativa: a population-based cross-sectional study from Denmark
  23. Pulmonary function in patients with psoriasis: across-sectional population study
  24. Frequency of Electrocardiographic Abnormalities in Patients With Psoriasis
  25. Intense pulsed light treatment for patients with hidradenitis suppurativa: beware treatment with resorcinol
  26. The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls
  27. Use of moisturizers among Danish atopic dermatitis patients-which perceived product characteristics associate with long-term adherence?
  28. Haematoxylin and eosin staining identifies medium to large bacterial aggregates with a reliable specificity: A comparative analysis of follicular bacterial aggregates in axillary biopsies using peptide nucleic acid-fluorescence in situ hybridization and h
  29. Spanish version of the Actinic Keratosis Quality of Life questionnaire
  30. Bacterial biofilm in chronic lesions of hidradenitis suppurativa
  31. Normal Skin Microbiota is Altered in Pre-clinical Hidradenitis Suppurativa
  32. Dermatobia hominis misdiagnosed as abscesses in a traveler returning from Brazil to Denmark
  33. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series
  34. Diagnostic accuracy of optical coherence tomography in actinic keratosis and basal cell carcinoma
  35. The Danish Nonmelanoma Skin Cancer Dermatology Database
  36. Dynamic Optical Coherence Tomography Capillaroscopy
  37. Validation of Dynamic optical coherence tomography for non-invasive, in vivo microcirculation imaging of the skin
  38. Pilonidal sinus: clinical and ultrasonographic response to topical resorcinol 15%
  39. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
  40. Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa
  41. Prevalence of delayed-type and immediate-type hypersensitivity in healthcare workers with hand eczema
  42. A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based onin vivoanalysis of optical properties by high-definition optical coherence tomography
  43. Optical coherence tomography of basal cell carcinoma: density and signal attenuation
  44. Adjunct use of optical coherence tomography increases the detection of recurrent basal cell carcinoma over clinical and dermoscopic examination alone
  45. In vivo assessment of optical properties of basal cell carcinoma and differentiation of BCC subtypes by high-definition optical coherence tomography
  46. Self-reported skin morbidity in Denmark: a population-based cross-sectional study
  47. What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysis
  48. Usefulness of ultrasound for the diagnosis of dermatofibroma
  49. In vivo, micro-morphological vascular changes induced by topical brimonidine studied by Dynamic optical coherence tomography
  50. Mechanical stress and the development of pseudo-comedones and tunnels in Hidradenitis suppurativa/Acne inversa
  51. Acquired Localized Cutis Laxa due to Increased Elastin Turnover
  52. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
  53. Self-reported pain management in hidradenitis suppurativa
  54. The Secret Scourge
  55. Hidradenitis Suppurativa
  56. Editorial
  57. Diagnosing Hidradenitis Suppurativa
  58. The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions
  59. Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases
  60. Pain in Hidradenitis Suppurativa: A Pilot Study
  61. A Population- and Hospital-based Cross-sectional Study of Renal Function in Hidradenitis Suppurativa
  62. Disutility in Patients with Hidradenitis Suppurativa: A Cross-sectional Study Using EuroQoL-5D
  63. Dynamic Optical Coherence Tomography in Dermatology
  64. Hidradenitis suppurativa may not be associated with venous thromboembolia: Results from a large Danish cross-sectional study
  65. Body composition and basal metabolic rate in Hidradenitis Suppurativa: a Danish population-based and hospital-based cross-sectional study
  66. Comment on ‘Transient memory impairment and transient global amnesia induced by photodynamic therapy’
  67. In vivo assessment of optical properties of melanocytic skin lesions and differentiation of melanoma from non-malignant lesions by high-definition optical coherence tomography
  68. Diagnostic delay in hidradenitis suppurativa is a global problem
  69. Hidradenitis suppurativa: A growing concern
  70. Hidradenitis suppurativa: Epidemiology and scope of the problem
  71. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes
  72. Is hidradenitis suppurativa associated with anaemia?: a population-based and hospital-based cross-sectional study from Denmark
  73. Cyclosporine treatment of severe Hidradenitis suppurativa – A case series
  74. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies
  75. Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software
  76. In vivomicro-angiography by means of speckle-variance optical coherence tomography (SV-OCT) is able to detect microscopic vascular changes in naevus to melanoma transition
  77. Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients
  78. Wound healing and all-cause mortality in 958 wound patients treated in home care
  79. Gallstones are associated with hidradenitis suppurativa
  80. The bacteriology of hidradenitis suppurativa: a systematic review
  81. A systematic review of terms used to describe hidradenitis suppurativa
  82. Methods to assess area and volume of wounds - a systematic review
  83. Through the looking‐glass, and what the dermatologist found there
  84. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
  85. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values
  86. High-definition optical coherence tomography intrinsic skin ageing assessment in women: a pilot study
  87. Recellularizing of human acellular dermal matrices imaged by high-definition optical coherence tomography
  88. Imaging of cutaneous T-cell lymphomas by optical coherence tomography - a case series study
  89. Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study
  90. The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
  91. Time Spent per delta PASI (TSdP) among psoriasis patients undergoing UVB-therapy – A pilot study
  92. Expert Advice Provided through Telemedicine Improves Healing of Chronic Wounds: Prospective Cluster Controlled Study
  93. Three-dimensional high-definition optical coherence tomography image acquisition procedure for basal cell carcinoma
  94. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients
  95. High-definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes
  96. Recurrence Rate and Patient Satisfaction of CO2 Laser Evaporation of Lesions in Patients With Hidradenitis Suppurativa
  97. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
  98. A case report of differentiating staphylococcal scalded skin syndrome and toxic epidermal necrolysis by optical coherence tomography
  99. Optical Coherence Tomography Imaging of the Skin
  100. Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
  101. Coagulation Status in Hidradenitis Suppurativa: A Danish Population- and Hospital-Based Cross-Sectional Study
  102. An Integrating Perspective
  103. How to Learn Most About Your Patients
  104. Recurring Axillary, Abdominal and Genitofemoral Nodules and Abscesses: A Quiz
  105. Actinic Keratosis
  106. Hand eczema and stratum corneum ceramides
  107. Association of Metabolic Syndrome and Hidradenitis Suppurativa
  108. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
  109. PIONEER II: Adalimumab Reduces Disease Activity in Patients with HS
  110. Hidradenitis Suppurativa
  111. Real-time three-dimensional imaging of epidermal splitting and removal by high-definition optical coherence tomography
  112. Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options
  113. Optical coherence tomography in the diagnosis of basal cell carcinoma
  114. Novel investigational therapies for atopic dermatitis
  115. Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study
  116. Differentiating allergic and irritant contact dermatitis by high-definition optical coherence tomography: a pilot study
  117. Optical Coherence Tomography and Cryosurgery
  118. Imaging of collagen deposition disorders using optical coherence tomography
  119. Assessing the quality of life over longer periods
  120. Pain and inflammation in hidradenitis suppurativa correspond to morphological changes identified by high-frequency ultrasound
  121. Delivery of Compression Therapy for Venous Leg Ulcers
  122. The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study
  123. Cost-Effective Use of Silver Dressings for the Treatment of Hard-to-Heal Chronic Venous Leg Ulcers
  124. Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects?
  125. The Role of Ultrasound in Severity Assessment in Hidradenitis Suppurativa
  126. Artefactual skin lesions in children and adolescents: review of the literature and two cases of factitious purpura
  127. Pattern of contact sensitization in patients with and without atopic dermatitis in a hospital-based clinical database
  128. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa
  129. Ultrasound as a Diagnostic Aid in Identifying Neurofibromas
  130. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions
  131. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease
  132. Standard Grading System for Rosacea
  133. Ingenol Mebutate: From Common Weed to Cancer Cure
  134. Optical Coherence Tomography and Its Role for Delineating the Thickness of Keratinocyte Dysplasia and Neoplasia
  135. In-vivo-Darstellung einerSarcoptes-scabiei-Infestation mittels optischer Kohärenztomographie
  136. Dermatophyte Prevalence in Tools of 43 Hairdressing Salons in Copenhagen
  137. Psoriasis – The Life Course Approach
  138. Interpretation of the Skin Cancer Quality of Life Score: A Validated Quality of Life Questionnaire for Non-Melanoma Skin Cancer
  139. The Influence of Body Weight on the Prevalence and Severity of Hidradenitis Suppurativa
  140. Is Adult Atopic Eczema More Common Than We Think? – A Population-based Study in Danish Adults
  141. Significant Differences in Nurses’ Knowledge of Basic Wound Management – Implications for Treatment
  142. Self-Reported Skin Morbidities and Health-Related Quality of Life: A Population-Based Nested Case-Control Study
  143. Quality of Life in Non-Melanoma Skin Cancer—The Skin Cancer Quality of Life (SCQoL) Questionnaire
  144. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
  145. Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis
  146. Ballistometer
  147. Successful Treatment of Severe Hidradenitis Suppurativa With Anakinra
  148. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy
  149. Photoallergic reactions to varenicline mimicking brachioradial pruritus
  150. High-definition optical coherence tomography imaging of melanocytic lesions: a pilot study
  151. Optical Coherence Tomography
  152. In vivo Imaging of Sarcoptes scabiei Infestation Using Optical Coherence Tomography
  153. Biomarkers in hidradenitis suppurativa
  154. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support
  155. Errata
  156. Disease quantification in dermatology: in vivo near-infrared spectroscopy measures correlate strongly with the clinical assessment of psoriasis severity
  157. Optical coherence tomography imaging of telangiectasias during intense pulsed light treatment: a potential tool for rapid outcome assessment
  158. Patients' perceptions of topical treatments of actinic keratosis
  159. Predicting response to anti-TNF-alpha treatment in Hidradenitis suppurativa
  160. Assessing the influence of actinic keratosis on patients’ quality of life: the AKQoL questionnaire
  161. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study
  162. High-definition optical coherence tomography: adapted algorithmic method for pattern analysis of inflammatory skin diseases: a pilot study
  163. Useful Dermatologic Classifications
  164. Glossary of Dermatological Terms
  165. Cumulative Life Course Impairment in Other Chronic or Recurrent Dermatologic Diseases
  166. Sonographic Anatomy of the Skin, Appendages, and Adjacent Structures
  167. Self-Inflicted Lesions in Dermatology: Terminology and Classification – A Position Paper from the European Society for Dermatology and Psychiatry (ESDaP)
  168. Development of a Clinical Scandinavian Registry for Hidradenitis Suppurativa; HISREG
  169. Erratum
  170. Erratum
  171. Dermatologic Ultrasound with Clinical and Histologic Correlations
  172. Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries
  173. Tumour Necrosis Factor-alpha and Matrix Metalloproteinase-2 are Expressed Strongly in Hidradenitis Suppurativa
  174. Infantile Acne Treated with Oral Isotretinoin
  175. Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
  176. Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial
  177. Improving quality of life in patients with hidradenitis suppurativa: a therapeutic view
  178. Imaging of basal cell carcinoma by high-definition optical coherence tomography: histomorphological correlation. A pilot study
  179. High-definition optical coherence tomography enables visualization of individual cells in healthy skin: comparison to reflectance confocal microscopy
  180. Severity Assessment and Outcome Measures in Acne Vulgaris
  181. Diagnostic accuracy in virtual dermatopathology
  182. Imaging Cutaneous T-Cell Lymphoma with Optical Coherence Tomography
  183. Hand eczema: prevalence and risk factors of hand eczema in a population of 2274 healthcare workers
  184. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study
  185. Peristomal Skin Complications Are Common, Expensive, and Difficult to Manage: A Population Based Cost Modeling Study
  186. Imaging the Nail Unit
  187. Exposures related to hand eczema: a study of healthcare workers
  188. Quality of life in atopic dermatitis: Changes over 6 years in patients who report persistent eczema
  189. Depression in patients with hidradenitis suppurativa
  190. Ceramide profile in hypohidrotic ectodermal dysplasia
  191. Imaging Granulomatous Lesions with Optical Coherence Tomography
  192. Hidradenitis suppurativa and immune dysregulation
  193. The efficacy of maggot debridement therapy - a review of comparative clinical trials
  194. Hidradenitis Suppurativa
  195. Cryosurgery Treatment of Actinic Keratoses Monitored by Optical Coherence Tomography: A Pilot Study
  196. Yellow plaques as cutaneous markers of internal disorders
  197. A Polycyclic Annular Erythematous Plaque on the Trunk: A Quiz
  198. The impact of ultraviolet therapy on stratum corneum ceramides and barrier function
  199. Teledermatology: The Atlantic Experience
  200. Do generalists and specialists agree on descriptive acne morphology?
  201. Hedgehog pathway does not play a role in hidradenitis suppurativa pathogenesis
  202. Long-term, continuous dosing of etanercept in patients with plaque psoriasis
  203. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
  204. Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
  205. How histological features of basal cell carcinomas influence image quality in optical coherence tomography
  206. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa
  207. Cumulative life damage in dermatology
  208. A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp
  209. Hidradenitis suppurativa: a review of cause and treatment
  210. Ultrasound detection and identification of cosmetic fillers in the skin
  211. Assessing peristomal skin changes in ostomy patients: validation of the Ostomy Skin Tool
  212. Comparative diagnostic accuracy in virtual dermatopathology
  213. Factors related to pain during routine photodynamic therapy: a descriptive study of 301 patients
  214. The Concept of ‘Smokers’ Boils’ Is Suggestive of a New Hypothesis on the Pathogenesis of Hidradenitis Suppurativa
  215. Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients
  216. Psychosocial Impact of Hidradenitis Suppurativa: A Qualitative Study
  217. Effects of Topical Corticosteroid and Tacrolimus on Ceramides and Irritancy to Sodium Lauryl Sulphate in Healthy Skin
  218. Stereological Estimation of Epidermal Volumes and Dermo-Epidermal Surface Area in Normal Skin
  219. Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation
  220. Ethnicity and stratum corneum ceramides
  221. Teledermatology with an integrated nurse - led clinic on the Faroe Islands - 7 years’ experience
  222. Treatment of hidradenitis suppurativa: Is oral isoniazid an option?
  223. Sensory Perception
  224. Dermatologic research in the Nordic countries 1989-2008 - a bibliometric study
  225. Skin barrier response to occlusion of healthy and irritated skin: Differences in trans-epidermal water loss, erythema and stratum corneum lipids
  226. The Ostomy Skin Tool: tracking peristomal skin changes
  227. Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides
  228. Current and future treatments of hidradenitis suppurativa
  229. Is the Dermatology Life Quality Index really time-sensitive?
  230. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions
  231. Skin problems in stoma patients
  232. Interobserver variability of clinical scores in hidradenitis suppurativa is low
  233. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema
  234. A simple method for routine measure of photodynamic therapy-associated pain
  235. Quality of life assessment among patients with peristomal skin disease
  236. Stratum corneum integrity as a predictor for peristomal skin problems in ostomates
  237. Photodynamic Therapy
  238. Prevention and Adjuvant Therapy
  239. Accuracy in the Diagnosis of Non-Melanoma Skin Cancer
  240. Anatomical Detection of Inflammatory Changes Associated with Plantar Warts by Ultrasound
  241. Comment on: Tattooing of skin results in transportation and light-induced decomposition of tattoo pigments
  242. Anaerobic digestion of tannery waste: Semi-continuous and anaerobic sequencing batch reactor processes
  243. Hidradenitis Suppurativa Complicating Naevus Comedonicus: The Possible Influence of Mechanical Stress on the Development of Hidradenitis Suppurativa
  244. Validation of Cyanoacrylate Method for Collection of Stratum Corneum in Human Skin for Lipid Analysis
  245. Ceramides and Barrier Function in Healthy Skin
  246. High Body Mass Index in Adolescent Girls Precedes Psoriasis Hospitalization
  247. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa
  248. To Cut or Not, That Is the Question
  249. Application of stereology to dermatological research
  250. A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus
  251. Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity
  252. Involuntary autonomy: Patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis
  253. Involuntary autonomy: Patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis☆
  254. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
  255. Optical Coherence Tomography for Imaging of Skin and Skin Diseases
  256. Improved quality of optical coherence tomography imaging of basal cell carcinomas using speckle reduction
  257. Which histological characteristics of basal cell carcinomas influence the quality of optical coherence tomography imaging?
  258. OCT imaging of skin cancer and other dermatological diseases
  259. Assessment of Optical Coherence Tomography Imaging in the Diagnosis of Non-Melanoma Skin Cancer and Benign Lesions Versus Normal Skin
  260. In vivothickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound
  261. Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases
  262. Alitretinoin – its use in intractable hand eczema and other potential indications
  263. Lymph Nodes in Hidradenitis Suppurativa
  264. Non-Surgical Treatment of Keratinocyte Skin Cancer
  265. Role of High-Variable Frequency Ultrasound in Preoperative Diagnosis of Glomus Tumors
  266. The Effect of Combined Treatment with Oral Clindamycin and Oral Rifampicin in Patients with Hidradenitis Suppurativa
  267. Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors
  268. Widespread Mycobacterium marinum Infection
  269. Skin Problems in Ostomy Patients: A Case-control Study of Risk Factors
  270. Stratum Corneum Damage and ex vivo Porcine Skin Water Absorption – A Pilot Study
  271. Photodynamic Therapy of Necrobiosis Lipoidica – A Multicenter Study of 18 Patients
  272. Optical coherence tomography imaging of bullous diseases
  273. Teledermatology on the Faroe Islands
  274. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial
  275. Peristomal skin problems account for more than one in three visits to ostomy nurses
  276. Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography
  277. Photodynamic Therapy With Methyl Aminolevulinate for Prevention of New Skin Lesions in Transplant Recipients: A Randomized Study
  278. FS03.4
Irritant dermatitis following tape stripping
  279. The revolutionary consequences of skin disease
  280. Viewpoint 1
  281. Lipids and skin barrier function – a clinical perspective
  282. What causes hidradenitis suppurativa?
  283. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
  284. Hidradénite suppurée
  285. Morphology and Epidermal Thickness of Normal Skin Imaged by Optical Coherence Tomography
  286. Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology
  287. Real-Time Compound Imaging Ultrasound of Hidradenitis Suppurativa
  288. Real-Time Compound Imaging Ultrasound of Hidradenitis Suppurativa
  289. Imaging of intradermal tattoos by optical coherence tomography
  290. Nail thickness measurements using optical coherence tomography and 20-MHz ultrasonography
  291. Diagnosis of Nonmelanoma Skin Cancer/Keratinocyte Carcinoma
  292. Diagnosis of Nonmelanoma Skin Cancer/Keratinocyte Carcinoma: A Review of Diagnostic Accuracy of Nonmelanoma Skin Cancer Diagnostic Tests and Technologies
  293. Assessment of atopic eczema: clinical scoring and noninvasive measurements
  294. Diagnostic potential of optical coherence tomography in non-melanoma skin cancer: a clinical study
  295. Imaging of cutaneous larva migrans by optical coherence tomography
  296. Photodynamic therapy in a series of rosacea patients
  298. Pain and Photodynamic Therapy
  299. Diagnostic Potential of Optical Coherence Tomography in Non-Melanoma Skin Cancer - A Clinical Study
  300. Outcomes in randomized controlled trials in psoriasis: What has changed over the last 20 years?
  301. Management of actinic keratosis patients: A qualitative study
  302. Successful Treatment of Necrobiosis Lipoidica Diabeticorum With Photodynamic Therapy
  303. Instrumental assessment of atopic eczema: Validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema
  304. Study of peristomal skin disorders in patients with permanent stomas
  305. A bibliometric study of dermatology in central Europe 1991–2002
  306. Ultrasound Imaging of Nails
  307. Life quality assessment among patients with atopic eczema
  308. Parent gender and assessment of infant life quality
  309. The handicap caused by atopic dermatitis - sick leave and job avoidance
  310. Handbook of Non-Invasive Methods and the Skin, Second Edition
  311. Ultrasound Imaging of Subcutaneous Tissue and Adjacent Structures
  312. Hidradenitis Suppurativa
  313. The bacterial flora of the skin surface following routine MAL‐PDT
  314. Mechanical Properties and Barrier Function of Healthy Human Skin
  315. Low‐dose allopurinol in the treatment of cutaneous sarcoidosis: Response in four of seven patients
  316. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial
  317. Photodynamic Therapy in the Treatment of Rosacea
  318. Methotrexate Use and Monitoring in Switzerland and Denmark
  319. Does visible atopic dermatitis affect quality of life more in women than in men?
  320. Time Spent on Treatment of Atopic Dermatitis: A New Method of Measuring Pediatric Morbidity?
  321. Acne: Treatment of scars
  322. Medical treatment of hidradenitis suppurativa
  323. Topical Therapy for Peristomal Pyoderma Gangrenosum
  324. Lipid raft-enriched stem cell-like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa
  325. Real-time spatial compound ultrasound imaging of skin
  327. HuMax-CD4
  328. Acne: comparing hormonal approaches to antibiotics and isotretinoin
  329. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa
  330. Mechanical properties of the skin: A comparison between two suction cup methods
  331. Nonmelanoma skin cancer in organ transplant patients
  332. Acne: comparing hormonal approaches to antibiotics and isotretinoin
  333. Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma
  334. Hidradenitis Suppurativa
  335. Hydration and Plasticity Following Long-term Use of a Moisturizer: A Single-blind Study
  336. Methotrexate is of limited value in the treatment of hidradenitis suppurativa
  337. The Mechanical Properties of Skin in Osteogenesis Imperfecta
  338. Have Oral Contraceptives Reduced the Prevalence of Acne? A Population-Based Study of Acne vulgaris, Tobacco Smoking and Oral Contraceptives
  339. Braces for Postoperative Bandage After Otoplasty
  340. The therapeutic potential of calcipotriol in diseases other than psoriasis
  341. Isotretinoin in Denmark - 20 years on
  342. Skin Irritation and Exposure to Diisocyanates in Orthopedic Nurses Working With Soft Casts
  343. Skin Irritation and Exposure to Diisocyanates in Orthopedic Nurses Working With Soft Casts
  344. Skin irritation and exposure to diisocyanates in orthopedic nurses working with soft casts
  345. Impact factors of dermatological journals for 1991 – 2000
  346. Impact factor to assess academic output
  347. Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients
  348. Crohn's disease presenting as a breast abscess: A case report
  349. Measuring skin mechanics. The soft touch in a hard environment?
  350. Measurement of the mechanical properties of skin with ballistometer and suction cup
  351. Morbidity in patients with hidradenitis suppurativa
  352. Vasculitis Occurring during Leflunomide Therapy
  353. Anxiety, Aggression, and Body Ideal in Adult Atopic Dermatitis Patients
  354. Moisturisers for Psoriatic Skin –Do Gross Morphological Differences Matter?
  355. Treatment of perforating collagenosis of diabetes and renal failure with allopurinol
  356. What's new in hidradenitis suppurativa?
  357. Ethical considerations
  358. The Inherent Capacitance of Moisturising Creams: A Source of False Positive Results?
  359. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa
  360. Hydration of human nails investigated by NIR-FT-Raman spectroscopy
  361. Correlation Between the Greasiness and the Plasticizing Effect of Moisturizers
  362. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis
  363. Gerda Frentz (1942?1998)
  364. Plasticising effect of water and glycerin on human skin in vivo
  365. Stellungnahme zur Arbeit von D. Abeck, H.C. Korting, M. Mempel: „Pyodermien”
  366. Evidence-based dermatologic out-patient treatment
  367. Quantitative evaluation of chronological ageing and photoageing in vivo: studies on skin echogenicity and thickness
  368. Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases
  369. The plastic sing effect of moisturizers on human skin in vivo: a measure of moisturizing potency?
  370. Quality assurance in dermatology - the development of a framework
  371. Ultrasound examination of hair follicles in hidradenitis suppurativa
  372. Pincer Nails and Alopecia as Markers of Gastrointestinal Malignancy
  373. The changing referral pattern in Danish dermatology - Rigshospitalet, Copenhagen, 1986-1995
  374. The homogeneity of hidradenitis suppurativa lesions
  375. Sebum Excretion in Hidradenitis suppurativa
  376. Measurement of skin mechanics.
  377. The prevalence of hidradenitis suppurativa and its potential precursor lesions
  378. Treatment of hyper-IgE dermatitis with interferon-γ
  379. Reply
  380. Treatment of hyper-IgE dermatitis with interferon-γ
  381. Histology of hidradenitis suppurativa
  382. Quality assurance in clinical dermatology - a need for tools
  383. Topical Treatment of Skin Ulcers in Prolidase Deficiency
  384. Topical Treatment of Skin Ulcers in Prolidase Deficiency
  385. Decreased Bone Mineral Density in Patients with Pustulosis palmaris et plantaris
  386. The Bacteriology of Hidradenitis suppurativa
  387. Coping and psoriasis ? a framework for targeted intervention
  388. Occupational allergic contact dermatitis from vitamin A acetate
  389. Microbiology of hidradenitis suppurativa
  390. Intra-individual variation of hidradenitis suppurativa
  391. Contact sensitization to dipropylene glycol in an eczema population
  392. Nail abnormalities in nondermatologic patients: Prevalence and possible role as diagnostic aids
  393. The influence of sex hormones on UVB induced erythema in man
  394. Erythema-index of clinical patch test reactions
  395. Dipropylene Glycol Allergy: A Hidden Cause of Perfume Contact Dermatitis
  396. Dipropylene Glycol Allergy: A Hidden Cause of Perfume Contact Dermatitis
  397. Cancer in patients treated with coal tar: a long-term follow up study
  398. Effect of cyclosporine on genital psoriasis and lichen planus
  399. Bone mineral density is unaffected by palmoplantar pustulosis
  400. Primary prevention of malignant melanoma: To know may not be enough
  401. Concomitant Psoriasis and Allergic Contact Dermatitis: Coexistent Interrelated Clinical Entities
  402. Concomitant Psoriasis and Allergic Contact Dermatitis: Coexistent Interrelated Clinical Entities
  403. Contact dermatitis from Brazilian box tree wood (Aspidospermasp.)
  404. Circulating androgens in male patients suffering from systemic scleroderma
  405. Side effects of cryotherapy
  406. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis
  407. Reply
  408. The Effect of Superficial Hydration on the Mechanical Properties of Human Skin in Vivo
  409. Unusual immediate adverse effects of photochemotherapy
  410. Short-term effects of topical 17β-oestradiol on human post-menopausal skin
  411. Ultrasound Structure of the Human Nail Plate
  412. Ultrasound structure of the human nail plate
  413. Bone lesions of acne fulminans
  414. Effect of localized surgical excisions in hidradenitis suppurativa
  415. Linear Atrophy Following Intralesional Steroid Injections
  417. Photographic surgery: Standards in clinical photography
  418. Hypertrichosis Lanuginosa Acquisita
  419. Hypertrichosis lanuginosa acquisita. Report of a case and review of the literature
  420. Suggestions for standardized clinical photography in plastic surgery
  421. Clinique
  422. Nosologie et classification
  423. Traitement
  424. Imaging
  425. Imagerie
  426. Traitements physiques expérimentaux
  427. Traitement immunodépresseur et hidradénite suppurée
  428. Traitement topique
  429. Affections associées : causalité ou complications?
  430. Topical Treatment
  431. Treatment
  432. Clinical Presentation
  433. Experimental Physical Therapies
  434. Associated Diseases: Causality or Complications?
  435. Immunosuppressive Therapy in Hidradenitis Suppurativa
  436. Nosology and Classification
  437. Optical Coherence Tomography: Technique and Applications